OncologyTube Professional - Patients Click Here
HoosierCancer
2,594 video views
Loading........
Description: Gregory A. Durm, MD, discusses a study whether PD-L1 expression on circulating tumor cells could help predict which patients might respond to certain immunotherapy treatments in lung cancer.
Indiana...
02:51
Gregory A. Durm, MD, discusses a study whether PD-L1 expression on circulating tumor cells could help predict which patients might respond to certain immunotherapy treatments in lung cancer. Indiana University School of Medicine http://www.h...
by:HoosierCancer | 1276 views
02:26
The causes of cachexia in pancreatic cancer patients and the need for funding for research. Safi Shahda, MD, http://www.h....
by:HoosierCancer | 470 views
03:05
An innovative approach to studying lung cancer metastases that originate from circulating tumor cells. Shadia Jalal, MD, http://www.h...
by:HoosierCancer | 296 views
09:27
This clinical trial is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear cell renal cell carcinoma following prior tyrosine kinase inhibitors. For more information please visit: http://www.h... http://clini......
by:HoosierCancer | 552 views

About HoosierCancer
Description: Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, is an independent not-for-profit organization established to explore and develop leading edge cancer treatments across the United States and internationally. Our clinical trials, developed in collaboration with academic and community oncologists, are conducted within a member network of more than 130 clinical research sites. Hoosier Cancer Research Network's vision and mission is to form unparalleled relationships between academic, community, pharmaceutical, and biotech partners with the goal of advancing cancer research, education, and patient advocacy. Our highly qualified team provides comprehensive study management and support, from conception and study design through project completion and publication.

Links
Channel Url:

Website:


Social Links: